Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
19.56
+0.81 (4.32%)
Apr 8, 2026, 1:23 PM EDT - Market open
Caris Life Sciences Employees
Caris Life Sciences had 1,846 employees as of December 31, 2025. The number of employees increased by 77 or 4.35% compared to the previous year.
Employees
1,846
Change
77
Growth
4.35%
Revenue / Employee
$439,888
Profits / Employee
-$291,418
Market Cap
5.53B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1,846 | 77 | 4.35% | 1,846 | 0 |
| Dec 31, 2024 | 1,769 | 1 | 0.06% | 1,769 | 0 |
| Dec 31, 2023 | 1,768 | - | - | 1,762 | 6 |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Apellis Pharmaceuticals | 739 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Mirum Pharmaceuticals | 372 |
| Xenon Pharmaceuticals | 370 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
CAI News
- 11 months ago - Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering - PRNewswire
- 11 months ago - Caris Life Sciences discloses rise in revenue in US IPO filing - Reuters
- 11 months ago - Oncology precision medicine platform Caris Life Sciences files for an estimated $300 million IPO - Renaissance Capital
- 11 months ago - Caris Life Sciences IPO Registration Document (S-1) - SEC